BSE: 524506 - Coral Laboratories Limited

Rentabilidad a seis meses: -19.84%
Rendimiento de dividendos: +0.23%

Calendario de promoción Coral Laboratories Limited


Acerca de la empresa Coral Laboratories Limited

Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethopia, and internationally.

más detalles
The company offers antibiotics/antibacterial products, including antifungal, antiemetic, analgesics/antipyretic/antiinflammatory, antispasmodic, anticold, antiallergic, antiasthmatic, antidiabetic, antiemetics, anthelmentic, thyroid, and antiprotozoal/antiamebic products; antimalarial drugs, antipsychotic drugs, gastro-intestinal drugs, kits, muscle relaxants, cough suppressant/expectorant products, cardiovascular medicines, oral antiseptic preparations, mouthwashes, calcium preparations, and appetizers; and nutritional, protein, and iron supplements, as well as other products. It also provides cephalosporin, beta lactam, and lyophilized injectable products; eye/ear/nose drops; nasal sprays and metered dose inhales; and large volume parenteral products. In addition, the company offers various nutraceutical products, such as dietary supplements, herbal/phytochemicals, multivitamins, and nutrients, as well as OTC products. It provides its products in various dosage forms, including tablets, capsules, low RH facilities, liquid orals, liquids and powders, dry syrups, drops, ointment and creams, gels and lotions, granules powders, injectables, nasal sprays, and suppositories. Coral Laboratories Limited was incorporated in 1994 and is headquartered in Mumbai, India.

Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.23
Дивиденд ао 2
Сайт http://corallab.com
Цена ао 757.6
Cambio de precio por día: -2.54% (747.35)
Cambio de precio por semana.: -1.55% (739.8)
Cambio de precio por mes: -9.81% (807.6)
Cambio de precio en 3 meses.: -4.44% (762.2)
Cambio de precio en seis meses: -19.84% (908.6)
Cambio de precio por año: +93.76% (375.9)
Cambio de precio en 3 años.: +114.98% (338.8)
Cambio de precio en 5 años.: +432.03% (136.9)
Cambio de precio desde principios de año.: -3.14% (751.95)

Subestimación

Nombre Significado Calificación
P/S 1.72 8
P/BV 0.7979 9
P/E 8.97 9
EV/EBITDA 0 0
Total: 8

Eficiencia

Nombre Significado Calificación
ROA, % 8.31 3
ROE, % 9.5 3
Total: 2

Dividendos

Nombre Significado Calificación
Div yield, % 0.23 0.58
DSI 0.9286 9.29
Total: 1.91

Deber

Nombre Significado Calificación
Debt/EBITDA 0 10
Total: 10

Impulso de crecimiento

Nombre Significado Calificación
Rentabilidad Revenue, % 16.32 3
Rentabilidad Ebitda, % 0 5
Rentabilidad EPS, % 121.44 10
Total: 7.6

Supervisor Título profesional Pago año de nacimiento
Mr. Girish Madanlal Dhameja Whole-Time Director 1981 (44 año)
Ms. Sushma Shashi Kadkade CFO & Non-Exec. Director 1976 (49 años)
Ms. Ruchi Anjaria Company Sec. & Compliance Officer
Mr. Kapil K. Shah Exec. Officer

DIRECCIÓN: India, Mumbai, #3B Patanwala Industrial Estate - abrir en mapas de google, abrir mapas de Yandex
Sitio web: http://corallab.com